U.S.
Pharma giant Pfizer (PFE) wants to expand human trials of its experimental coronavirus vaccine to thousands of test patients by September, CEO and Chairman Albert …
Pfizer Inc (PFE) plans to shift more of its medicine production to outside contractors to prepare for potential large-scale production of its experimental Covid-19 …
Amid asset sale speculation and the cycle of earnings season, analysts from Mizuho, Maxim, and Merrill Lynch are offering insights into the key …
Merrill Lynch dives into the biotech world as analysts explore positive catalysts for giants Gilead Sciences, Inc. (NASDAQ:GILD) and Pfizer Inc.
Today’s biggest news is coming from Pfizer Inc. (NYSE:PFE), which announced its offer to acquire Medivation Inc (NASDAQ:MDVN) in a stock deal worth …
Piper Jaffray analyst Richard Purkiss reiterates his Overweight rating on Pfizer Inc. (NYSE:PFE) with a price target of $54.
BTIG analyst Tim Chiang weighed in today with a cautious stance on the “Mega Inversion” deal between Pfizer Inc.(NYSE:PFE) and Allergan PLC (NYSE:AGN), where Pfizer would acquire Allergan …
